Return to search

Carrier-mediated transport of norepinephrine transporter substrates

An overview of the noradrenergic system, including the identification of norepinephrine (NE) in animal tissue, its synthesis and metabolism, adrenoceptor classification, peripheral and central actions, uptake and storage, and mechanisms of NE release are presented. After characterizing the kinetic, ion dependence and inhibitor sensitivity of the norepinephrine transporter (NET) expressed in a recombinant cell line (LLC-NET cells), the influence of catecholamine (CA) metabolizing enzymes on studies of transport was assessed. Inhibitors of catechol-O-methyltransferase (COMT) potentiated the apparent uptake and retention of [3H]NE and [3H]DA. COMT inhibition had a greater influence on [3H]DA than [3H]NE uptake and retention, which corresponds to the higher spontaneous loss of radiolabel from cells exposed to [3H]DA than [3H]NE ([3H]methoxytyramine, is more lipophilic than [3H]normetanephrine). The monoamine oxidase inhibitor, pargyline, had no augmentary action on [3H]CA uptake, but actually inhibited substrate influx by blocking the NET. [3H]substrate specific differences were demonstrated for [3H]NE, [3H]DA and [3H]MPP+. For a given length of exposure to low Na+ or tyramine, [3H]NE release was the lowest, but most sensitive to NET inhibitors. Disparities in the kinetics of each [3H]substrate for the inwardly facing NET may account for this. Inhibitors of the NET were found to stimulate the efflux of [3H]substrates from preloaded cells incubated in a physiological HEPES buffer. Efflux was NET-dependent and differed greatly for each [3H]substrate. Inhibitor-induced release was greatest for [3H]MPP+ and least for [3H]NE. Finally, a functional model of carrier-mediated NE release in myocardial ischemia, was developed in this study. Release of [3H]MPP+ was stimulated by Na+-H+ exchanger (NHE) activation and modulated by inhibitors of the NET, NHE, Na+,K+-ATPase, and via a receptor-operated pathway. Excessive NE release contributes to severe myocardial arrhythmias, therefore an improved understanding of the carrier-mediated NE release process will ultimately enhance our ability to intervene and prevent the deleterious effects of excessive NE release.

Identiferoai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:310713
Date January 2000
CreatorsSmith, Neil C. E.
PublisherUniversity of Surrey
Source SetsEthos UK
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation
Sourcehttp://epubs.surrey.ac.uk/843076/

Page generated in 0.0017 seconds